D.E. Shaw & Co’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-47,361
Closed -$2.29M 3339
2025
Q1
$2.29M Buy
47,361
+41,657
+730% +$2.01M ﹤0.01% 1777
2024
Q4
$220K Sell
5,704
-21,121
-79% -$815K ﹤0.01% 2707
2024
Q3
$1.21M Buy
26,825
+13,673
+104% +$615K ﹤0.01% 2083
2024
Q2
$456K Sell
13,152
-22,488
-63% -$779K ﹤0.01% 2533
2024
Q1
$1.03M Buy
+35,640
New +$1.03M ﹤0.01% 2094
2023
Q3
Sell
-72,686
Closed -$2.01M 3218
2023
Q2
$2.01M Sell
72,686
-126,830
-64% -$3.5M ﹤0.01% 1750
2023
Q1
$4.59M Buy
199,516
+11,480
+6% +$264K ﹤0.01% 1378
2022
Q4
$2.05M Buy
188,036
+44,961
+31% +$491K ﹤0.01% 2031
2022
Q3
$1.21M Buy
+143,075
New +$1.21M ﹤0.01% 2449
2022
Q1
Sell
-43,286
Closed -$1.48M 4432
2021
Q4
$1.48M Sell
43,286
-72,627
-63% -$2.48M ﹤0.01% 2540
2021
Q3
$2.05M Sell
115,913
-132,322
-53% -$2.34M ﹤0.01% 2089
2021
Q2
$11.1M Buy
248,235
+47,255
+24% +$2.12M 0.01% 992
2021
Q1
$5.21M Sell
200,980
-135,876
-40% -$3.52M 0.01% 1332
2020
Q4
$6.79M Sell
336,856
-190,977
-36% -$3.85M 0.01% 1156
2020
Q3
$10.3M Sell
527,833
-285,113
-35% -$5.57M 0.01% 885
2020
Q2
$14.4M Buy
812,946
+532,412
+190% +$9.4M 0.02% 723
2020
Q1
$1.98M Sell
280,534
-149,983
-35% -$1.06M ﹤0.01% 1525
2019
Q4
$3.04M Buy
430,517
+100,348
+30% +$707K ﹤0.01% 1418
2019
Q3
$3.97M Sell
330,169
-67,109
-17% -$806K ﹤0.01% 1250
2019
Q2
$4.81M Buy
397,278
+139,550
+54% +$1.69M 0.01% 1188
2019
Q1
$3.24M Buy
257,728
+238,083
+1,212% +$2.99M ﹤0.01% 1351
2018
Q4
$132K Buy
19,645
+8,450
+75% +$56.8K ﹤0.01% 2436
2018
Q3
$115K Sell
11,195
-39,066
-78% -$401K ﹤0.01% 2429
2018
Q2
$337K Buy
+50,261
New +$337K ﹤0.01% 2283
2018
Q1
Sell
-31,251
Closed -$650K 2630
2017
Q4
$650K Buy
+31,251
New +$650K ﹤0.01% 1983